Literature DB >> 11803512

Examination of genetic linkage of chromosome 15 to schizophrenia in a large Veterans Affairs Cooperative Study sample.

D W Tsuang1, A D Skol, S V Faraone, S Bingham, K A Young, S Prabhudesai, S L Haverstock, F Mena, A S Menon, D Bisset, J Pepple, F Sauter, C Baldwin, D Weiss, J Collins, M Boehnke, G D Schellenberg, M T Tsuang.   

Abstract

Previous studies have reported genetic linkage evidence for a schizophrenia gene on chromosome 15q. Here, chromosome 15 was examined by genetic linkage analysis using 166 schizophrenia families, each with two or more affected subjects. The families, assembled from multiple centers by the Department of Veterans Affairs Cooperative Study Program, consisted of 392 sampled affected subjects and 216 affected sibling pairs. By DSM-III-R criteria, 360 subjects (91.8%) had a diagnosis of schizophrenia and 32 (8.2%) were classified as schizo-affective disorder, depressed. Participating families had diverse ethnic backgrounds. The largest single group were northern European American families (n = 62, 37%), but a substantial proportion was African American kindreds (n = 60, 36%). The chromosome 15 markers tested were spaced at intervals of approximately 10 cM over the entire chromosome and 2-5 cM for the region surrounding the alpha-7 nicotinic cholinergic receptor subunit gene (CHRNA7). These markers were genotyped and the data analyzed using semiparametric affecteds-only linkage analysis. In the European American families, there was a maximum Z-score of 1.65 between markers D15S165 and D15S1010. These markers are within 1 cM from CHRNA-7, the site previously implicated in schizophrenia. However, there was no evidence for linkage to this region in the African America kindreds. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11803512

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  28 in total

Review 1.  The genetics of sensory gating deficits in schizophrenia.

Authors:  Robert Freedman; Ann Olincy; Randall G Ross; Merilyne C Waldo; Karen E Stevens; Lawrence E Adler; Sherry Leonard
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

2.  Genetic interaction between alpha4 and beta2 subunits of high affinity nicotinic receptor: analysis in schizophrenia.

Authors:  Vincenzo De Luca; Sophocles Voineskos; Greg Wong; James L Kennedy
Journal:  Exp Brain Res       Date:  2006-04-25       Impact factor: 1.972

Review 3.  Molecular genetics of schizophrenia: a critical review.

Authors:  Neeraj Berry; Vaidehi Jobanputra; Hemraj Pal
Journal:  J Psychiatry Neurosci       Date:  2003-11       Impact factor: 6.186

Review 4.  Linkage studies of schizophrenia.

Authors:  Brien Riley
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

5.  Transcriptional repression of the α7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2α (AP-2α).

Authors:  Jessica Finlay-Schultz; Andrew Canastar; Margaret Short; Mohamed El Gazzar; Christina Coughlan; Sherry Leonard
Journal:  J Biol Chem       Date:  2011-10-06       Impact factor: 5.157

6.  The α7 nicotinic acetylcholine receptor and the acute stress response: maternal genotype determines offspring phenotype.

Authors:  Melissa L Sinkus; Marianne Z Wamboldt; Amanda Barton; Tasha E Fingerlin; Mark L Laudenslager; Sherry Leonard
Journal:  Physiol Behav       Date:  2010-11-10

7.  A 2-base pair deletion polymorphism in the partial duplication of the alpha7 nicotinic acetylcholine gene (CHRFAM7A) on chromosome 15q14 is associated with schizophrenia.

Authors:  Melissa L Sinkus; Michael J Lee; Judith Gault; Judith Logel; Margaret Short; Robert Freedman; Susan L Christian; Jennifer Lyon; Sherry Leonard
Journal:  Brain Res       Date:  2009-07-23       Impact factor: 3.252

8.  The chimeric gene CHRFAM7A, a partial duplication of the CHRNA7 gene, is a dominant negative regulator of α7*nAChR function.

Authors:  Tanguy Araud; Sharon Graw; Ralph Berger; Michael Lee; Estele Neveu; Daniel Bertrand; Sherry Leonard
Journal:  Biochem Pharmacol       Date:  2011-06-28       Impact factor: 5.858

Review 9.  Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors:  Ann Olincy; Karen E Stevens
Journal:  Biochem Pharmacol       Date:  2007-07-17       Impact factor: 5.858

10.  Association of the 5'-upstream regulatory region of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) with schizophrenia.

Authors:  Sarah H Stephens; Judith Logel; Amanda Barton; Alexis Franks; Jessica Schultz; Margaret Short; Jane Dickenson; Benjamin James; Tasha E Fingerlin; Brandie Wagner; Colin Hodgkinson; Sharon Graw; Randal G Ross; Robert Freedman; Sherry Leonard
Journal:  Schizophr Res       Date:  2009-01-31       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.